Skip to main content
. 2023 May 2;66(3):E246–E263. doi: 10.1503/cjs.005922

Table 6.

Pregnancy and percutaneous procedure (pregnancy or gynecology) management protocols for patients with inherited bleeding disorders2,40,59,7281

Condition Primary coagulation issue Female bleeding phenotype Pregnancy: factor change ante partum and/or at delivery* Percutaneous procedure
Product Time before/after Further dosing; regional anesthesia
von Willebrand disease
 Type 1 vWF level decreased Mild to moderate Increase vWF-containing concentrates or desmopressin vWF-containing factor VIII concentrate ≤ 4 h/1–3 d
  • Once per day

  • Yes if prior > 12 h

 Type 2 Dysfunctional vWF Variable/moderate Small increase in vWF-containing concentrates vWF-containing factor VIII concentrate ≤ 4 h/1–3 d
  • Once per day

  • Yes if prior > 12 h

 Type 3 vWF absent Severe No increase in vWF-containing concentrates vWF-containing factor VIII concentrate ≤ 2 h/> 3–5 d
  • Once or twice per day

  • Yes if prior > 8 h

Hemophilia A Factor VIII level decreased Mild to moderate, with factor VIII level < 40 IU/dL
  • Ante partum: increase factor VIII or desmopressin

  • Delivery: factor VIII replacement as required

Recombinant factor VIII ≤ 2 h/> 3–5 d
  • Once or twice per day

  • Yes if prior > 8 h

Hemophilia B Factor IX level decreased Mild to moderate, with factor IX level < 40 IU/dL
  • No increase

  • Delivery: factor XI replacement as required

Recombinant factor IX ≤ 2 h/> 3–5 d
  • Once per day

  • Yes if prior > 8 h

Glanzmann thrombasthenia Platelet function disorder Associated with severe bleeding phenotype
  • Avoid blood or platelet transfusion during pregnancy

  • Delivery: HLA-matched platelets transfused

Bernard–Soulier syndrome Platelet receptor abnormality Associated with severe bleeding phenotype
  • Avoid blood or platelet transfusion during pregnancy

  • Delivery: HLA-matched platelets transfused

Factor XI deficiency Factor XI level decreased Highly variable but increased with factor XI level < 15 IU/dL
  • No increase

  • Delivery: factor XI replacement

  • Factor XI concentrate (plasma-derived)

  • Fresh frozen plasma in emergency or if no factor XI concentrate

≤ 8 h/1–3 d
  • Once per day

  • Yes if prior > 12 h

HLA = human leukocyte antigen; vWF = von Willebrand factor.

*

If factor level is less than 40 IU/dL.

Pregnancy-related (prenatal diagnosis, regional anesthesia), gynecologic or pelvic endoscopy.